Screening and Diagnosis | Personalized Treatment
Accounting for nearly half of all cancers in the U.S., skin cancer is the most common of all cancers. Melanoma, the most serious type of skin cancer, accounts for more than 76,000 cases of skin cancer annually.
Skin Cancer Screening and Diagnosis
The best screening for skin cancer is a self-exam of your skin. Any signs or symptoms should be discussed with your physician. An easy way of remember signs and symptoms is the “ABCDEs” of melanoma:
Asymmetry: Moles that are unequal in size from one half to the other.
Border: Moles with irregular, scalloped or undefined border.
Color: Variations in mole color (including tan to brown, black, red or blue)
Diameter: Moles with a diameter larger than a pencil eraser (> 6 mm)
Elevation: Moles that are raised (elevated) from the skin.
Patients who present with suspicious symptoms to their primary care physician will most likely undergo a biopsy (for melanoma detection) of potentially affected tissue by a dermatologist or a surgeon. Diagnosis is then confirmed through pathology tests of the tissue.
If a diagnosis of skin cancer is made, a physician will determine the severity or stage of the cancer, including whether it has spread to other areas of the body.
Personalized Melanoma Treatment
Malignant melanoma of the skin has the fastest rising incidence of any cancer in the United States. Melanoma is the less common form of skin cancer, has a higher chance of spread than the more common skin cancer. While options for treating melanoma remain limited, Kellogg Cancer Center's multidisciplinary melanoma program offers the depth and breadth of experience to utilize complicated new therapeutics. NorthShore also treats other rare forms of skin cancer, including Merkel cell carcinoma.
For patients with late stage melanoma, NorthShore is one of the few institutions in the region to offer immunotherapy with high-dose bolus Interleukin-2 therapy and Ipilimumab. The administration of Interleukin-2 is extremely complex, and NorthShore has the requirements of both highly knowledgeable oncologists and Intensive Care Unit (ICU) staff.
Administering Ipilimumab is very involved, with unique autoimmune side effects that can affect multiple organ systems and require attention from multiple specialists. Our endocrinology and gastroenterology programs are key components of the multidisciplinary team caring for patients on this drug.
Recently, the Federal Drug Administration (FDA) approved several drugs for patients who have specific mutations in the BRAF and related genes. NorthShore’s Molecular Pathology Department is one of the few programs testing for this mutation on-site, allowing for very quick implementation of this lifesaving drug.
Multimodal strategies combining surgery, chemotherapy, radiation therapy and sophisticated medications often are used to ensure optimal outcomes for patients with melanoma.
In some cases, melanoma may spread or recur within an arm or leg, which can be painful or disfiguring and pose the threat of spreading to other parts of the body. NorthShore has one of only a few physicians in the country who perform complex isolated limb perfusions and isolated limb infusions to treat this challenging condition. This procedure saves patients from amputation and helps control tumors that otherwise might spread beyond the affected limb.
NorthShore’s highly trained specialists also are able to perform stereotactic radiosurgery and laser thermal ablation for patients with brain metastases—cases in which melanoma has spread to the brain. These advanced procedures allow neurosurgical experts teamed with radiation oncologists to precisely target various tumors in hard-to-reach areas of the brain where conventional surgery is not an option.
For More Information
For more information or to schedule an appointment with one of our specialists, please call 847.570.2112.